Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction.

Source:http://linkedlifedata.com/resource/pubmed/id/12815575

Download in:

View as

General Info

PMID
12815575